SNSE/ABBV (SNSE/ABBV)

Santiago Stock Exchange: SNSE/ABBV · USD

$283

+0.00 (0.0%)· Recorded snapshot

Market cap	499.7T
Revenue (ttm)	59.3T
Net income (ttm)	5.8T
EPS (ttm)	$3,495
P/E (trailing)	79.9x
P/E (forward)	19.0x
Dividend	$6,604 (2.37%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 59.3T
Net income (ttm): 5.8T
EPS (ttm): $3,495
P/E (trailing): 79.9x
P/E (forward): 19.0x
Market cap: 499.7T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19

P25 n/aP50 n/aP75 n/a

Trailing P/E79.9

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC17.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SNSE/ABBV indicators

Market & fundamental data

Available fields

207

Groups with data

Currency

USD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CLP
Country	United States
Country code	CL
Earnings date	2026-10-30
Employees	57,000
Employees change	2,000
Employees growth	3.64%
Enterprise value	$563T
Exchange	Santiago Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-09-17
Fiscal year end	December
Founded	2012
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US00287Y1091
Last refreshed	2026-10-28
Market cap	$499.7T
Next earnings date	2026-10-30
Price	$282.68
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	snse/ABBV
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	41.3x
Average P/E ratio (3Y)	81.44x
Average P/E ratio (5Y)	58.76x
Earnings yield	1.25%
EV/Earnings	96.98x
EV/EBIT	24.92x
EV/EBITDA	18.31x
EV/FCF	33.39x
EV/Sales	8.86x
FCF / EV yield	2.99%
FCF yield	3.38%
Forward P/E	19.01x
Lynch fair value	$16.43
Lynch upside	-94.19%
P/(FCF - SBC) ratio	31.3x
P/(OCF - SBC) ratio	29.11x
P/E ratio	79.86x
P/FCF ratio	29.63x
P/OCF ratio	27.66x
P/S ratio	8.38x
Price/EBITDA ratio	17.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	35.56%
EBITDA margin	47.78%
Effective tax rate	27.39%
FCF margin	26.39%
Gross margin	72.79%
Operating margin	35.56%
Pretax margin	13.51%
Profit margin	9.8%
Profit per employee	$101.3M
Profitable quarters	6
Profitable years	17
Revenue per employee	$1B
ROA	10.51%
ROA (5Y)	8.68%
ROCE	24.49%
ROE (5Y)	1,295.17%
ROIC	17.7%
ROIC (5Y)	21.99%
SBC / revenue	1.52%
Tax / revenue	3.7%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	68.54%
EPS growth (Q)	290.39%
EPS growth (QoQ)	422.72%
EPS growth 10Y	0.21%
EPS growth 3Y	-10.05%
EPS growth 5Y	-0.92%
EPS growth quarters	1
EPS growth years	0
FCF growth	-0.16%
FCF growth (Q)	-36.24%
FCF growth (QoQ)	-12.63%
FCF growth 3Y	-9.78%
FCF growth 5Y	-1.43%
Gross profit growth	12.78%
Gross profit growth (Q)	14.64%
Gross profit growth 3Y	5.88%
Gross profit growth 5Y	5.07%
Net income growth	67.69%
Net income growth (Q)	285.18%
Net income growth (QoQ)	424.16%
Net income growth 3Y	-10.12%
Net income growth 5Y	-1.02%
Net income growth quarters	1
Net income growth years	0
OCF growth	1.16%
OCF growth (Q)	-33.32%
OCF growth (QoQ)	-10.26%
OCF growth 10Y	9.1%
OCF growth 3Y	-8.59%
OCF growth 5Y	-0.94%
Operating income growth	21.17%
Operating income growth (Q)	17.54%
Operating income growth 3Y	3.56%
Operating income growth 5Y	3.75%
Revenue growth	10.39%
Revenue growth (Q)	10.16%
Revenue growth (QoQ)	13.25%
Revenue growth 10Y	10.03%
Revenue growth 3Y	4.75%
Revenue growth 5Y	3.69%
Revenue growth quarters	10
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.2T
Depreciation and amortization	$7.8T
EBIT	$21.1T
EBITDA	$28.3T
EPS	$3,495.35
Financing cash flow	$-11.9T
Free cash flow	$16.8T
Free cash flow minus SBC	$15.9T
Gross profit	$43.2T
Income taxes	$2.2T
Investing cash flow	$-6T
Net borrowing	$412.8B
Net cash flow	$94B
Net income	$5.8T
Operating cash flow minus SBC	$17.1T
Operating income	$21.1T
Revenue	$59.3T
Stock-based compensation	$899.2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.42
Book value per share	$-3,094.34
Debt / EBITDA	2.28
Debt / FCF	3.89
Goodwill	$35.1T
Interest coverage	7.85
Long-term assets	$91.2T
Long-term liabilities	$88.8T
Net cash (debt)	$-59.3T
Net cash / market cap	-11.92%
Net debt / EBITDA	2.09
Net debt / FCF	3.53
Piotroski F-Score	8
Property, plant and equipment	$5.7T
Shareholders' equity	$-5.4T
Tangible book value	$-83.5T
Tangible book value per share	$-47,232.63
Total assets	$124.5T
Total cash	$6.1T
Total debt	$65.3T
Total liabilities	$129.9T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.47
Current assets	$33.2T
Current liabilities	$41.1T
Current ratio	0.81
Inventory turnover	3.47
Net working capital	$-5.7T
Quick ratio	0.49
Working capital	$-7.3T
Working capital turnover	-6,420.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.03%
Dividend growth	5.49%
Dividend growth years	2
Dividend payment date	2026-11-16
Dividend payment years	4
Dividend payout frequency	Quarterly
Dividend per share	$6,604.31
Dividend yield	2.37%
Ex-dividend date	2026-10-15
Last dividend	$1.73
Payout ratio	189.83%
Shareholder yield	2.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0%
1M price change	6.88%
1M total return	7.56%
1W price change	3.03%
1W total return	3.03%
20-day SMA	$271.78
3M price change	11.56%
3M total return	12.27%
50-day SMA	$263.88
52-week high	$282.68
52-week high date	2026-10-26
52-week low	$245.10
52-week low date	2026-08-10
All-time high	$282.68
All-time high date	2026-10-20
All-time low	$245.10
All-time low date	2026-08-04
Average true range (ATR)	$1.17
Average volume	0
Change from 52-week high	0%
Change from 52-week low	15.33%
Change from all-time high	0%
Change from all-time low	15.33%
Monthly RSI	0
Previous close	$282.68
Price vs 20-day SMA	4.01%
Price vs 50-day SMA	7.12%
RSI	88.02
Sharpe ratio	1.86
Sortino ratio	3.2
Weekly RSI	0

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.8B
Shares change (QoQ)	-0.23%
Shares change (YoY)	0.03%
Shares held by insiders	0.07%
Shares held by institutions	76.58%
Short ratio	3.2 days

Deeper analysis on SNSE/ABBV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SNSE/ABBV report

Is a complete SNSE/ABBV research report available?

No complete published report is available for snse/ABBV (SNSE/ABBV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SNSE/ABBV (SNSE/ABBV)

Price

Financial snapshot

Fair-value bridge

Latest news · SNSE/ABBV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNSE/ABBV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNSE/ABBV

Frequently asked questions